HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Clyde, D. F. Search for Related Content PubMed PubMed Citation Articles by Clyde, D. F.

Chloroquine Treatment for Malaria in Semi-Immune Patients

For semi-immune Africans reared in districts of malarial holoendemicity in East Africa, the following single doses of chloroquine phosphate (recorded as base) are effective in the treatment of malaria caused by any species of parasite and appear to achieve radical cure of subtertian malaria: age 0 to 1 year, 19 mg; 1 to 2 years, 37 mg; 3 to 5 years, 75 mg; and 6 years and older, 120 mg. For suppression, the respective dosages are 19 mg, 37 mg, 75 mg, and 75 mg.

The doses used for treatment clear parasitemia, fever and symptoms attributable to malaria as quickly as do larger doses and stimulate less vomiting. They should precede courses of suppressive treatment.